Program Description
Precision medicine in
chronic obstructive pulmonary disease (COPD) aims to tailor treatment based on
individual characteristics, such as phenotype, biomarkers, and treatable
traits, to personalize care and improve outcomes. Despite advances, managing
COPD remains challenging due to its heterogeneity and progression. Precision
medicine, especially for type 2 inflammation, is transforming treatment by
targeting the right therapy to the right patient. Chronic disease state
management is a part of the pharmacist’s evolving clinical role, which includes
COPD, and pharmacists should be able to support precision medicine treatment
strategies to assess drug appropriateness, increase adherence, and reduce
exacerbations and hospitalizations. This activity will address the inflammatory
processes of COPD and strategies using phenotyping, biomarkers, and treatable
traits to provide treatment of COPD and bring attention to the health
disparities and the impact they have on quality of life for patients living
with COPD. With a greater understanding of precision medicine treatment
strategies for COPD, pharmacists will be better equipped to contribute to
clinical decision-making in COPD teams and manage and assess appropriate
therapies for individual patients to help reduce implications of COPD on public
health.
Target Audience: Ambulatory Care Pharmacist,
Community Pharmacist, Consultant Pharmacist, Health System Pharmacist, Retail
Pharmacist
Type of Activity: Application
Release date: December
5, 2025
Expiration date: December
5, 2026
Learner
level: Foundational,
Intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify healthcare disparities and highlight the clinical and economic burden of chronic obstructive pulmonary disease (COPD).
- Analyze the inflammatory process and key type 2 inflammation characteristics.
- Explore precision medicine treatment strategies, including phenotyping, biomarkers, and treatable traits for patients with COPD.